What are the risks of myocardial revascularization in pregnant women with NSTE-ACS?
Pregnant women with NSTE-ACS who undergo myocardial revascularization may experience in-hospital and long-term complications such as bleeding, heart failure, cardiogenic shock, acute renal failure, recurrent myocardial infarction, stroke, and readmissions. Furthermore, women with NSTE-ACS may be more likely to suffer from bleeding complications and renal failure than men. Additionally, women may be underprescribed guideline-directed pharmacological therapy, both during the acute illness and at discharge.  